Showing results (221-230 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neurology|October 27, 2023
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsLaynie Dratch, Meron Azage, Aaron Baldwin, et al.
Science (New York, N.Y.)|October 2, 2020
Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tauNabil F Darwich, Jessica M Phan, Boram Kim, et al.
Journal of Neuropathology and Experimental Neurology|January 24, 2023
The status of digital pathology and associated infrastructure within Alzheimer's Disease CentersRebeca Scalco, Yamah Hamsafar, Charles L White, et al.
Acta Neuropathologica Communications|May 28, 2025
Operationalizing postmortem pathology-MRI association studies in Alzheimer's disease and related disorders with MRI-guided histology samplingChinmayee Athalye, Alejandra Bahena, Pulkit Khandelwal, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2013
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease BiobankJon B Toledo, Vivianna M Van Deerlin, Edward B Lee, et al.
Acta Neuropathologica|May 9, 2020
Distribution patterns of tau pathology in progressive supranuclear palsyGabor G Kovacs, Milica Jecmenica Lukic, David J Irwin, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal DementiaYanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 3, 2012
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosisDavid J Irwin, Corey T McMillan, Johannes Brettschneider, et al.
Neurology|February 2, 2024
Evaluation of ATN<sub>PD</sub> Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson DiseaseKatheryn A Q Cousins, David J Irwin, Thomas F Tropea, et al.
Pageof 29